Walmart halts H-1B visa offers amid Trump’s $100,000 fee increase - Bloomberg
Jonathan M. Rothberg, a director and ten percent owner of Quantum-Si Inc (NASDAQ:QSI), sold 26,095 shares of Class A Common Stock on October 16, 2025, for approximately $80,111. The shares were sold at prices ranging from $3.07 to $3.09. According to InvestingPro data, QSI’s stock has shown significant volatility, with the current price at $2.28 and a market capitalization of $465 million. The stock has demonstrated strong momentum, gaining over 98% in the past six months, despite currently trading below the insider’s sale price.
The sale was executed pursuant to a pre-arranged 10b5-1 trading plan established on September 13, 2024, for estate planning purposes. With a beta of 2.91, QSI shows higher volatility than the broader market. InvestingPro analysis reveals 12 additional key insights about QSI’s financial health and market position, helping investors make more informed decisions about insider transactions.
Following the transaction, Rothberg continues to indirectly own 1,904,866 shares through NVR TR, LLC. Rothberg also indirectly owns shares through JNR TR, LLC (1,930,960 shares), GBR TR, LLC (1,930,960 shares), EJR TR, LLC (1,930,960 shares), JAR TR, LLC (1,250,000 shares), 23rd Century Capital LLC (1,917,067 shares), Bonnie E Gould Rothberg MD (273,422 shares), 4C Holdings I, LLC (17,943,750 shares of Class B Common Stock), and 4C Holdings V, LLC (1,993,750 shares of Class B Common Stock). Rothberg also directly owns 2,568,443 shares. Based on current market prices, these holdings represent a significant portion of the company’s total market value. For detailed analysis of QSI’s ownership structure and comprehensive financial metrics, access the full Pro Research Report available on InvestingPro.
In other recent news, Quantum-Si Inc. reported its earnings for the second quarter of 2025, showing a mixed financial performance. The company posted an earnings per share of -$0.16, slightly missing the forecast of -$0.14. Although there was a revenue surprise of 15.7% over expectations, the actual revenue was $591,000, which fell short of some estimates. Additionally, Quantum-Si entered into a sales agreement with Leerink Partners LLC, allowing the company to offer and sell up to $100 million of its Class A common stock through at-the-market offerings. This agreement gives Quantum-Si the flexibility to sell shares at its discretion, with Leerink Partners acting as the sales agent or principal. In product development, Quantum-Si launched its V4 Sequencing Kit, compatible with both Platinum and Platinum Pro instruments. This new kit enhances protein analysis capabilities by improving sequencing coverage, including glycine recognition and enhanced alanine and serine recognition.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.